82.80
price up icon3.59%   2.87
 
loading

Finanzdaten der Dexcom Inc-Aktie (DXCM)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
9.77%
1,308.40
1,191.90 1,259.60 1,209.30 1,157.10
Cost Of Revenue
8.33%
478.40
441.60 466.90 477.90 468.30
Gross Profit
10.62%
830.00
750.30 792.70 731.40 688.80
Operating Expenses
3.37%
511.70
495.00 469.70 488.90 476.20
Depreciation and Amortization
6.84%
12.50
11.70 11.40 9.60 9.30
Operating Income/Loss
24.68%
318.30
255.30 323.00 242.50 212.60
Income/Loss From Continuing Operations Before Tax
17.81%
317.50
269.50 340.70 352.30 241.10
Income Tax Expense/Benefit, Deferred
200.00%
-0.30
0.30 78.90 118.00 -8.90
Income Tax Expense/Benefit
2.29%
68.40
70.00 73.40 68.50 61.30
Net Income/Loss
24.86%
249.10
199.50 267.30 283.80 179.80
Basic Average Shares
0.75%
382.20
385.10 -1.20 391.10 392.10
Diluted Average Shares
0.89%
390.10
393.60 -2.20 407.40 408.20
Basic Earnings Per Share
25.00%
0.65
0.52 0.69 0.73 0.46
Diluted Earnings Per Share
25.49%
0.64
0.51 0.67 0.70 0.45
$76.55
price up icon 0.16%
PHG PHG
$26.95
price down icon 0.65%
STE STE
$227.48
price down icon 2.01%
ZBH ZBH
$95.53
price down icon 1.99%
$240.04
price down icon 1.01%
PEN PEN
$319.29
price down icon 0.83%
Kapitalisierung:     |  Volumen (24h):